SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VD's Model Portfolio & Discussion Thread
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Andrew H who wrote (596)5/16/1997 2:12:00 AM
From: Vector1   of 9719
 
Andrew, I believe transgenic production will prove to be a cost effective way to produce therapudic protiens and as a leader in the field GZTC has almost unlimited potential. However, as BIOWA stated no phase III is a slam dunk and there are still a number of issues that some scientists have with transgenic production the most important one that I am familiar with is the risk of passing some unknown compound along with the protien. Biowa, Rocket you guys have any thoughts on this.
V1
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News